NCT02245438View on ClinicalTrials.gov

Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

June 30, 2002

Conditions
Healthy
Interventions
DRUG

Tipranavir low dose

DRUG

Tipranavir high dose

DRUG

Ritonavir low dose

DRUG

Ritonavir high dose

DRUG

Norethindrone-Ethinyl Estradiol

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02245438 - Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers | Biotech Hunter | Biotech Hunter